- Recruiting
Ph 2: Carfilzomib & lenalidomide-based treatment for newly diagnosed primary plasma cell leukemia
EMN12/HOVON129 Study
Phase 2: To evaluate progression-free survival in adult pPCL patients by incorporation of carfilzomib and lenalidomide in induction, consolidation, and maintenance therapy

Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients.
HOVON HO129 PCL
Multicenter, intergroup, phase 2 study
Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients.
Start Date: 2015-08-10
Stop Date: 2023-08-10
Netherlands Trial Register - Trial NL5202 (NTR5350)